Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Breast Cancer Metastatic × Cyclophosphamide × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Multiple Myeloma 3 Burkitt Lymphoma 3 Myelodysplastic Syndromes 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia 2 Solid Tumors 1 Rhabdomyosarcoma 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms, Plasma Cell 1 Neoplasms by Site 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myeloid, Acute 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Graft vs Host Disease 1 Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement 1 Disease Progression 1 Congenital Abnormalities 1 Breast Diseases 1 Breast Cancer Metastatic 1 Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited 1

Interventions

Cyclophosphamide 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04350021 2024-01-17

METRO

Vastra Gotaland Region

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡